Yassmine Akkari

Yassmine Akkari works in clinical and cancer genomics, focusing on how genetic and chromosomal changes in tumors and blood cancers are detected, interpreted, and reported in diagnostic laboratories. Much of the work involves developing standards and guidelines (often with professional bodies like ACMG and CAP) for technologies such as next-generation sequencing and optical genome mapping, which are used to identify chromosomal abnormalities and gene fusions in cancers and rare genetic disorders. This research is oriented toward improving clinical laboratory practice and consistency in genetic test reporting rather than basic discovery science.

Publication output has grown substantially over the last decade, rising from single digits per year around 2017-2020 to a sustained higher output of roughly 15-22 papers per year since 2022.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026